Northland Capmk Has Strong Forecast for CVE:HIV Q3 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Northland Capmk upped their Q3 2026 earnings per share estimates for shares of HIVE Blockchain Technologies in a report issued on Wednesday, January 29th. Northland Capmk analyst M. Grondahl now anticipates that the company will earn $0.11 per share for the quarter, up from their prior forecast of $0.07.

HIV has been the subject of a number of other reports. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Finally, Roth Capital upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th. Four investment analysts have rated the stock with a strong buy rating, Based on data from MarketBeat, the company has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies (CVE:HIV) last issued its quarterly earnings data on Tuesday, November 12th. The company reported C($0.08) EPS for the quarter, topping the consensus estimate of C($0.12) by C$0.04. During the same period in the previous year, the business posted ($0.39) EPS.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.